Beyond Chemical Imbalance: New Frontiers in Psychiatry with Dr. Theodore Henderson - #37

Beyond Chemical Imbalance: New Frontiers in Psychiatry with Dr. Theodore Henderson - #37In this episode of the Neurostimulation Podcast, host Mike welcomes Dr. Theodore Henderson, a pioneering psychiatrist and neuroscientist whose work is reshaping the field of mental health. Dr. Henderson challenges the traditional "chemical imbalance" model of psychiatric disorders, advocating for a more nuanced understanding rooted in neuroimaging, neuroplasticity, and the biology of inflammation.Key Topics Discussed:Dr. Henderson’s Journey: From a background in neurobiology and radiology to psychiatry, and how questioning the status quo led him to innovative treatments.Moving Beyond Chemical Imbalance: Why the serotonin hypothesis is outdated, and how new research points to neuroplasticity and mitochondrial health as central to mental wellness.Neuroimaging and Diagnosis: The role of SPECT scans in identifying brain dysfunction, traumatic brain injury, and differentiating between psychiatric conditions.Infrared Light Therapy (Photobiomodulation): How Dr. Henderson’s research has advanced the use of infrared light to stimulate brain repair, neuroplasticity, and recovery from conditions like depression, chronic fatigue syndrome, and traumatic brain injury.Ketamine and Synergistic Treatments: The science behind ketamine’s effects on neuroplasticity, and how combining it with infrared therapy can yield powerful results.Neuroinflammation and Viral Triggers: Insights into how chronic fatigue, depression, and even some cases of Parkinson’s and Alzheimer’s may be linked to viral infections and neuroinflammation.Long COVID: Dr. Henderson’s approach to treating long COVID symptoms, including fatigue and brain fog, with antiviral therapies and infrared light.Personalized Psychiatry: The importance of moving away from a “cookbook” approach to mental health, and embracing individualized, biomarker-driven diagnostics and treatments.Future Directions: The promise of next-generation transcranial magnetic stimulation (TMS), ongoing research collaborations, and the need for broader access to innovative therapies.Actionable Insights:Clinicians: Consider neuroinflammatory and viral contributions to psychiatric symptoms; basic blood tests and antibody panels can be informative.Patients: There is hope beyond standard medications—emerging therapies may offer new avenues for recovery.Resources:Dr. Henderson’s book: Brighter Days Ahead (link in show notes)Dr. Henderson’s clinic and contact information (link in show notes)Connect with Dr. Henderson:https://neuro-luminance.com/about/https://neuro-luminance.com/brighter-days-ahead/If you’re interested in the future of mental health treatment, from infrared laser therapy to the role of neuroinflammation, this episode is essential listening.